Price Transparency Tool Doesn't Cut Health Care Spending

This article originally appeared here.
Share this content:
Price Transparency Tool Doesn't Cut Health Care Spending
Price Transparency Tool Doesn't Cut Health Care Spending

WEDNESDAY, May 4, 2016 (HealthDay News) -- Employee use of a price transparency tool does not cut health care spending, according to a study published in the May 3 issue of the Journal of the American Medical Association.

Sunita Desai, Ph.D., from Harvard Medical School in Boston, and colleagues measured the association between offering a health care price transparency tool and outpatient spending. The tool was offered by two large employers in multiple market areas across the United States (148,655 employees) and provided users information about what they would pay out of pocket for services from different physicians, hospitals, or other clinical sites. Results in the year before and after the tool's introduction were compared to 295,983 employees at other companies not offered the tool

The researchers found that mean outpatient spending among employees offered the tool was $2,021 in the year before the tool was introduced and $2,233 in the year after, compared to $1,985 and $2,138, respectively, in the control group. Being offered the tool was associated with a mean $59 increase in outpatient spending, after adjusting for demographic and health characteristics. After adjustments, being offered the price transparency tool was associated with a mean $18 increase in out-of-pocket spending. Ten percent of employees who were offered the tool used it at least once in the first 12 months.

"Among employees at two large companies, offering a price transparency tool was not associated with lower health care spending," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »